Join Growin Stock Community!

Oaktree acquisition corp. iii life sciences unitOACCU.US Overview

US StockIndustrials
(No presentation for OACCU)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

OACCU AI Insights

OACCU Overall Performance

OACCU AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

OACCU Recent Performance

-

Oaktree acquisition corp. iii life sciences unit

0.28%

Avg of Sector

-0.31%

S&P500

OACCU PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

OACCU Key Information

OACCU Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

OACCU Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Price of OACCU

OACCU FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

OACCU Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.11
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is OACCU's latest earnings report released?

    The most recent financial report for Oaktree acquisition corp. iii life sciences unit (OACCU) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating OACCU's short-term business performance and financial health. For the latest updates on OACCU's earnings releases, visit this page regularly.

  • How much cash does OACCU have?

    At the end of the period, Oaktree acquisition corp. iii life sciences unit (OACCU) held Total Cash and Cash Equivalents of 1.39M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • What are the PEG ratio and PE ratio of OACCU?

    The latest valuation data shows Oaktree acquisition corp. iii life sciences unit (OACCU) has a Price-To-Earnings (PE) ratio of 0.04 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.